Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT06812117
A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
720
Enrollment(s)
30
Study location(s)
OBSERVATIONAL (None)
Diabetic Peripheral Neuropathic Pain
NOT_YET_RECRUITING
NCT06797622
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
50
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
Metastatic Breast Cancer
NOT_YET_RECRUITING
NCT06785727
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
612
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Ischemic Stroke
Transient Ischemic Attack
COMPLETED
NCT06740825
Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects
32
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
RECRUITING
NCT06740799
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
12
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE1)
Hepatic Impairment
RECRUITING
NCT06718179
Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents
3,150
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
RECRUITING
NCT06691191
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
48
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
16
17
18
19
20